The European Pharmaceutical Wholesale Industry: - phagro

More documents

Recommendations

Info

15 The European Pharmaceutical Wholesale Industry Figure 10: Market Share of the 3 leading full-line Wholesalers per Country (CR 3), 2004 4.2 Sales 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 82 76 74 IPF Institute for Pharmaeconomic Research 62 FR AUT NL GER UK IT ESP Source: Alliance Unichem 2004, ANZAG 2004, Celesio 2004, GIRP data, IPF research, Phoenix 2004, As competition increases, market consolidation is under way. Companies seek to reap economies of scale to preserve their competitiveness. In 2004, the three biggest pharmaceutical wholesalers held more than 46.5% of the European market (EU-22). The pharmaceutical wholesale industry generated sales 3 of more than 104 billion EUR in the EU-22 in 2004. About 92% of these sales the industry generated in the countries of the “old” EU. The former communist eastern European countries, which have joined the EU in May 2004, hold roughly 8% of the total European wholesale market. Austria, France, Germany, Italy, the Netherlands, Spain and the UK together generated sales of 81.37 billion EUR, holding a market share of 78% in the EU-22. Thus, analysis made on this 7-country basis can claim to be representative for the whole market consisting of 22 countries. The biggest market was Germany with sales of 19.70 billion EUR, followed by France and the UK with 18.54 and 13.75 billion EUR respectively. In the accession countries, the pharmaceutical wholesale industry generated sales of 8.30 billion EUR, of which almost 50% were earned in Poland. Despite the dominant position of the Polish market in this region, from a European point of view (EU-22) Poland’s market share of 3.90% is comparatively small. 3 Sales were computed on a wholesale or pharmacy purchase price basis before rebates and without VAT. 52 43 40
The European Pharmaceutical Wholesale Industry Figure 11: Market Share of AUT, ESP, FR, GER, IT, NL, UK in EU-22 full-line wholesalers’ sales, 2004 10.1% 4.0% 1.8% 4.0% 1.8% 12.2% 13.2% 22.0% 17.8% 18.9% AUT ESP FR GER GER IT NL UK Rest of EU-22 Source: GIRP data, IPF research The development of absolute sales figures indicates a steady growth of the pharmaceutical wholesale market by 26.27% from 2000 to 2004. However, the different national markets developed very inconsistently over the last few years. Whereas total wholesale sales grew steeply in Spain, the market in other countries like the UK, France or Austria grew only moderately. After several years of growth, the Dutch market showed a downturn in sales in 2004. A similar development can be found in Germany, although the market used to grow not as strong as the Dutch one did until 2003. But the drop in sales in 2004 hit the German wholesale industry harder than wholesalers in the Dutch market. Figure 12: Development of full-line Wholesalers’ Sales, 2000-2004 170 160 150 140 130 120 110 100 90 Index, Year 2000 = 100 2000 2001 2002 2003 2004 AUT ESP FR GER IT NL UK EU-22 Source: GIRP data, IPF research IPF Institute for Pharmaeconomic Research 16
Page 1: ��
Page 4 and 5: Contents a The European Pharmaceuti
Page 6 and 7: Figures c The European Pharmaceutic
Page 8 and 9: The European Pharmaceutical Wholesa
Page 10 and 11: III The European Pharmaceutical Who
Page 12 and 13: V The European Pharmaceutical Whole
Page 14 and 15: VII The European Pharmaceutical Who
Page 18 and 19: 1 Introduction 1 The European Pharm
Page 22 and 23: 5 The European Pharmaceutical Whole
Page 28 and 29: 11 The European Pharmaceutical Whol
Page 40 and 41: 23 75 74 73 72 71 70 The European P
Page 60 and 61: 43 40 35 30 25 20 15 10 5 0 The Eur
Page 82 and 83:
65 The European Pharmaceutical Whol
Page 84 and 85:
67 The European Pharmaceutical Whol
Page 86 and 87:
9 Bibliography 69 The European Phar
show all

The European Pharmaceutical Wholesale Industry: - phagro

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?